Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus and Thymoglobulin in Renal Transplants
NCT00006178Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Aug 2000
- Primary completion
- Dec 2007
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus, antithymocyte globulin in kidney transplant rejection, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Aug 2000; status: completed.
02
Drugs
sirolimusantithymocyte globulin
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00006178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006178.